feed,title,long_url,short_url
Benzinga,FDA Approves Agios' Mitapivat As First Disease-Modifying Therapy For Genetic Blood Disorder,https://benzinga.com/general/biotech/22/02/25709572/fda-approves-agios-mitapivat-as-first-disease-modifying-therapy-for-genetic-blood-disorder,https://bit.ly/3gU2FJk
